par Myriam Guiral | Nov 5, 2026 | Digital Health, E-health & MedTech, MedTech & Biotech Insights
RESIL.IO Health has officially obtained CE marking as a Class I medical device under EU MDR 2017/745, and is now registered in EUDAMED with the reference SRN: FR-MF-000058145. This milestone marks a significant step in the deployment of digital therapeutics for cancer...
par Myriam Guiral | Nov 5, 2026 | Adventures & Resilience, Cancer & Health, Workplace & Inclusion
Three Octobers. Three Pink Ribbon months. Three years as a patient navigating the complex, often invisible terrain of life after a breast cancer diagnosis. And each year, the question becomes clearer: who is there to support women in their professional reconstruction...
